A PHASE III RANDOMIZED STUDY ON POSTOPERATIVE RADIO- AND CHEMOTHERAPY [cisplatin] IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 02 Jul 2012 Biomarkers information updated
- 23 Sep 2005 New trial record.